켄터키의 소세포 폐암 임상 시험
소세포 폐암 관련 연구 16개가 켄터키 내 여러 지역에서 참여자를 모집하고 있습니다.
켄터키의 도시
공식 연구 텍스트(영어)
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- University of Kentucky Medical Center, Lexington
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07707895DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Norton Cancer Institute, Downtown, Louisville
- Pikeville Medical Center, Pikeville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07472517A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
- Baptist Health, Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07459634A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Baptist Health Lexington /ID# 277729, Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07155174A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 115, Louisville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05914116A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
- University of Kentucky, Lexington
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07564401A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Norton Cancer Institute, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT07218146Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Baptist Health Hardin Cancer Center, Elizabethtown
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06712355A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Baptist Health Louisville /ID# 280025, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07365241Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Norton Cancer Institute, Louisville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
- Site 1004, Louisville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07407933A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Baptist Health Lexington, Lexington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06203210DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- University of Kentucky Medical Center, Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT05882058Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Baptist Health Corbin, Corbin
- Baptist Health Lexington, Lexington
- Baptist Health Hamburg, Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 30. 업데이트됨 · NCT06769126Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Robley Rex VA Medical Center, Louisville, KY, Louisville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 11. 업데이트됨 · NCT06681220A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
- Zelgen Site 103, Lexington
피험자 모집 중1상
18세 ~ 75세 · 모든 성별 · 2025. 8. 6. 업데이트됨 · NCT06592638ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.